Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity
Open Access
- 1 November 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (46), 45826-45832
- https://doi.org/10.1074/jbc.m309024200
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to boneThe FASEB Journal, 2002
- Early Detection of Bone Metastases in a Murine Model Using Fluorescent Human Breast Cancer Cells: Application to the Use of the Bisphosphonate Zoledronic Acid in the Treatment of Osteolytic LesionsJournal of Bone and Mineral Research, 2001
- American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast CancerJournal of Clinical Oncology, 2000
- Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problemCancer Treatment Reviews, 2000
- Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.JCI Insight, 1998
- Cancer and BoneEndocrine Reviews, 1998
- General mechanisms of metastasisCancer, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Metastatic bone disease: Clinical and therapeutic aspectsBone, 1992